118 related articles for article (PubMed ID: 2955245)
21. Differential effects of D1 and D2 dopamine receptor agonists on substantia nigra pars reticulata neurons.
Waszczak BL
Brain Res; 1990 Apr; 513(1):125-35. PubMed ID: 2140951
[TBL] [Abstract][Full Text] [Related]
22. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
Sonsalla PK; Manzino L; Heikkila RE
J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
[TBL] [Abstract][Full Text] [Related]
23. Responses of substantia nigra pars reticulata neurons to GABA and SKF 38393 in 6-hydroxydopamine-lesioned rats are differentially affected by continuous and intermittent levodopa administration.
Weick BG; Engber TM; Susel Z; Chase TN; Walters JR
Brain Res; 1990 Jul; 523(1):16-22. PubMed ID: 2119854
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
Engber TM; Marin C; Susel Z; Chase TN
Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
[TBL] [Abstract][Full Text] [Related]
25. Topography of dopamine behaviours mediated by D1 and D2 receptors revealed by intrastriatal injection of SKF 38393, lisuride and apomorphine in rats with a unilateral 6-hydroxydopamine-induced lesion.
Fletcher GH; Starr MS
Neuroscience; 1987 Feb; 20(2):589-97. PubMed ID: 2953990
[TBL] [Abstract][Full Text] [Related]
26. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.
Jiang HK; McGinty JF; Hong JS
Brain Res; 1990 Jan; 507(1):57-64. PubMed ID: 1967976
[TBL] [Abstract][Full Text] [Related]
27. Dopaminergic and cholinergic stimulation of the ventrolateral striatum elicit rat jaw movements that are funnelled via distinct efferents.
Adachi K; Hasegawa M; Fujita S; Sato M; Miwa Y; Ikeda H; Koshikawa N; Cools AR
Eur J Pharmacol; 2002 May; 442(1-2):81-92. PubMed ID: 12020685
[TBL] [Abstract][Full Text] [Related]
28. Coexistence of inhibitory dopamine D-1 and excitatory D-2 receptors on the same caudate nucleus neurons.
Ohno Y; Sasa M; Takaori S
Life Sci; 1987 May; 40(19):1937-45. PubMed ID: 3553819
[TBL] [Abstract][Full Text] [Related]
29. Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression.
Sivam SP; Breese GR; Krause JE; Napier TC; Mueller RA; Hong JS
J Neurochem; 1987 Nov; 49(5):1623-33. PubMed ID: 2889804
[TBL] [Abstract][Full Text] [Related]
30. Dopamine D1 heteroreceptors on striatonigral axons are not stimulated by endogeneous dopamine either tonically or after amphetamine: evidence from terminal excitability.
Ryan LJ; Diana M; Young SJ; Groves PM
Exp Brain Res; 1989; 77(1):161-5. PubMed ID: 2529134
[TBL] [Abstract][Full Text] [Related]
31. D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour.
Robertson HA; Peterson MR; Murphy K; Robertson GS
Brain Res; 1989 Dec; 503(2):346-9. PubMed ID: 2532558
[TBL] [Abstract][Full Text] [Related]
32. Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
Merchant KM; Bush LG; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1990 Nov; 255(2):775-80. PubMed ID: 2147039
[TBL] [Abstract][Full Text] [Related]
33. (-)-Stepholidine acts as a D1 partial agonist on firing activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine-lesioned rats.
Sun BC; Zhang XX; Jin GZ
Life Sci; 1996; 59(4):299-306. PubMed ID: 8761001
[TBL] [Abstract][Full Text] [Related]
34. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.
Gerfen CR; Engber TM; Mahan LC; Susel Z; Chase TN; Monsma FJ; Sibley DR
Science; 1990 Dec; 250(4986):1429-32. PubMed ID: 2147780
[TBL] [Abstract][Full Text] [Related]
35. Bromocriptine-induced locomotor stimulation in mice is modulated by dopamine D-1 receptors.
Jackson DM; Hashizume M
J Neural Transm; 1987; 69(1-2):131-45. PubMed ID: 2953861
[TBL] [Abstract][Full Text] [Related]
36. Methylxanthines reverse the adipsic and aphagic syndrome induced by bilateral 6-hydroxydopamine lesions of the nigrostriatal pathway in rats.
Casas M; Prat G; Robledo P; Barbanoj M; Kulisevsky J; Jané F
Pharmacol Biochem Behav; 2000 Jun; 66(2):257-63. PubMed ID: 10880677
[TBL] [Abstract][Full Text] [Related]
37. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
Turski WA; Cavalheiro EA; Ikonomidou C; Bortolotto ZA; Klockgether T; Turski L
Synapse; 1990; 5(2):113-9. PubMed ID: 2137942
[TBL] [Abstract][Full Text] [Related]
38. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
Pollack AE; Yates TM
Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
[TBL] [Abstract][Full Text] [Related]
40. Metabolic mapping of the synergism between MK-801 and SKF 38393 in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
Pontieri FE; Morelli M; Orzi F; Terenzi R; Di Chiara G
Synapse; 1992 Dec; 12(4):255-60. PubMed ID: 1465740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
